AXGT - Axovant Gene Therapies Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development141,412134,77876,64434,377.6
Selling General and Administrative71,90645,72156,51816,132.8
Non Recurring----
Total Operating Expenses213,318180,499133,16250,510.4
Operating Income or Loss-213,318-180,499-133,162-50,510.4
Income from Continuing Operations
Total Other Income/Expenses Net-7,334-1,512--
Earnings Before Interest and Taxes-213,318-180,499-133,162-50,510.4
Interest Expense-7,545-1,143-1,143-1,143
Income Before Tax-220,652-182,011-133,162-50,510.4
Income Tax Expense921-1,060-172.4
Minority Interest----
Net Income From Continuing Ops-221,573-180,951-133,145-50,512.8
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-221,573-180,951-133,145-50,512.8
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-221,573-180,951-133,145-50,512.8